These Analysts Slash Their Forecasts On Science Applications International Following Q2 Results

Science Applications International (SAIC) reported mixed Q2 results, with sales declining 3% year-over-year to $1.77 billion, missing analyst estimates, while adjusted EPS of $3.63 significantly beat consensus. The company subsequently revised its 2026 revenue outlook downwards to $7.25 billion-$7.325 billion, below analyst expectations, but raised its annual adjusted EPS guidance to $9.40-$9.60, exceeding consensus. CEO Toni Townes-Whitley attributed the more cautious revenue outlook to a stable but not improving operating environment, contributing to SAIC's shares falling 1.7%.

Analysis

Science Applications International (SAIC) presented mixed second-quarter results, characterized by a clear divergence between top-line pressure and bottom-line strength. The company's quarterly sales declined 3% year-over-year to $1.77 billion, missing the consensus estimate of $1.86 billion. This revenue weakness is projected to continue, as management significantly lowered its 2026 revenue outlook to a range of $7.250-$7.325 billion, well below the prior guidance and analyst consensus. Conversely, SAIC demonstrated strong profitability, posting an adjusted EPS of $3.63 that substantially surpassed the $2.24 consensus estimate, and subsequently raised its full-year adjusted EPS guidance to $9.40-$9.60. CEO Toni Townes-Whitley attributed the cautious revenue outlook to a "stable but not improving" operating environment. The market reacted negatively, with shares falling 1.7%, indicating that investors are currently weighing the revenue headwinds more heavily than the demonstrated margin strength. Analyst actions were a modest recalibration, with Stifel lowering its price target to $128 while maintaining a Buy rating, and UBS trimming its target to $110 while maintaining a Neutral stance.

Key Decisions for Investors

• Investors must weigh SAIC's strong operational efficiency and EPS outperformance against its deteriorating revenue outlook, which now extends to its long-term 2026 forecast.
• Monitor future contract awards and management commentary on the operating environment, as the revised guidance assumes no near-term improvement, making any positive shift a potential catalyst.
• Consider that the negative stock reaction and cautious analyst price target revisions suggest the market is prioritizing top-line growth concerns over the company's demonstrated profitability.
• Given the conflicting signals, the stock may now be more suitable for investors with a value orientation focused on profitability rather than those seeking high-growth opportunities.